1. Interfractional robustness of scanning carbon ion radiotherapy for prostate cancer: An analysis based on dose distribution from daily in‐room CT images
- Author
-
Shinichi Minohara, Yoshiki Takayama, Yohsuke Kusano, Keisuke Tsuchida, Nobutaka Mizoguchi, Tadashi Kamada, Koh Imura, Wataru Anno, Kio Kano, Daisaku Yoshida, Itsuko Serizawa, Hiroyuki Katoh, Tatsuya Ohno, and Yosuke Takakusagi
- Subjects
scanning irradiation ,Male ,Planning target volume ,Rectum ,interfractional movement ,Heavy Ion Radiotherapy ,Computed tomography ,Dose distribution ,Image guided radiotherapy ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,medicine ,Radiation Oncology Physics ,Humans ,Initial treatment ,Radiology, Nuclear Medicine and imaging ,in‐room CT ,Instrumentation ,Radiation ,medicine.diagnostic_test ,business.industry ,Radiotherapy Planning, Computer-Assisted ,carbon ion radiotherapy ,Prostatic Neoplasms ,Radiotherapy Dosage ,image‐guided radiotherapy ,prostate cancer ,medicine.disease ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Carbon Ion Radiotherapy ,Tomography, X-Ray Computed ,business ,Nuclear medicine - Abstract
Purpose We analyzed interfractional robustness of scanning carbon ion radiotherapy (CIRT) for prostate cancer based on the dose distribution using daily in‐room computed tomography (CT) images. Materials and Methods We analyzed 11 consecutive patients treated with scanning CIRT for localized prostate cancer in our hospital between December 2015 and January 2016. In‐room CT images were taken under treatment conditions in every treatment session. The dose distribution on each in‐room CT image was recalculated, while retaining the pencil beam arrangement of the initial treatment plan. Then, the dose–volume histogram (DVH) parameters including the percentage of the clinical target volume (CTV) with 95% and 90% of the prescribed dose area (V95% of CTV, V90% of CTV) and V80% of rectum were calculated. The acceptance criteria for the CTV and rectum were set at V95% of CTV ≥95%, V90% of CTV ≥98%, and V80% of rectum < 10 ml. Results V95% of CTV, V90% of CTV, and V80% of rectum for the reproduced plans were 98.8 ± 3.49%, 99.5 ± 2.15%, and 4.39 ± 3.96 ml, respectively. Acceptance of V95% of CTV, V90% of CTV, and V80% of rectum was obtained in 123 (94%), 125 (95%) and 117 sessions (89%), respectively. Acceptance of the mean dose of V95% of CTV, V90% of CTV, and V80% of rectum for each patient was obtained in 10 (91%), 10 (91%), and 11 patients (100%), respectively. Conclusions We demonstrated acceptable interfractional robustness based on the dose distribution in scanning CIRT for prostate cancer.
- Published
- 2021
- Full Text
- View/download PDF